Gemtuzumab ozogamicin, cytosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. (Q46974006)
Jump to navigation
Jump to search
scientific article published on 28 September 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gemtuzumab ozogamicin, cytosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. |
scientific article published on 28 September 2007 |
Statements
Gemtuzumab ozogamicin, cytosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia (English)
L Pagano
F Leoni
S Storti
A Scardocci
M Caira
28 September 2007